# Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)

> **NCT04210375** · PHASE1 · COMPLETED · sponsor: **Salubris Biotherapeutics Inc** · enrollment: 14 (actual)

## Conditions studied

- Heart Failure With Reduced Ejection Fraction

## Interventions

- **DRUG:** JK07
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT04210375
- **Lead sponsor:** Salubris Biotherapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-21
- **Primary completion:** 2023-06-08
- **Final completion:** 2023-07-07
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04210375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04210375, "Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04210375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*